최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Pulmonary circulation, v.9 no.1, 2019년, pp.2045894018788846 -
Desole, Susanna (Division of Pneumology and Infectious Diseases”, Ernst-Moritz-Arndt University, Germany) , Richter, Manuel Jonas (Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Germany) , Heine, Alexander (Division of Pneumology and Infectious Diseases”, Ernst-Moritz-Arndt University, Germany) , Ewert, Ralf (Division of Pneumology and Infectious Diseases”, Ernst-Moritz-Arndt University, Germany)
Intravenous prostacyclin-based therapy improves survival in children with pulmonary arterial hypertension (PAH), but is typically administered via an external infusion pump, which places a considerable burden on the patient. Implanted pumps may overcome some of the limitations of external pumps. We ...
1 Abman SH Hansmann G Archer SL et al. Pediatric pulmonary hypertension: Guidelines from the American Heart Association and American Thoracic Society . Circulation 2015 ; 132 : 2037 – 2099 . 26534956
2 Barst RJ Maislin G Fishman AP Vasodilator therapy for primary pulmonary hypertension in children . Circulation 1999 ; 99 : 1197 – 1208 . 10069788
3 Nakayama T Shimada H Takatsuki S et al. Efficacy and limitations of continuous intravenous epoprostenol therapy for idiopathic pulmonary arterial hypertension in Japanese children . Circ J 2007 ; 71 : 1785 – 1790 . 17965503
4 Yung D Widlitz AC Rosenzweig EB et al. Outcomes in children with idiopathic pulmonary arterial hypertension . Circulation 2004 ; 110 : 660 – 665 . 15289375
5 Lammers AE Hislop AA Flynn Y et al. Epoprostenol treatment in children with severe pulmonary hypertension . Heart 2007 ; 93 : 739 – 743 . 17065181
6 Hansmann G Apitz C Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK . Heart 2016 ; 102 ( Suppl 2 ): ii67 – ii85 . 27053700
7 Simonneau G Barst RJ Galie N et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial . Am J Respir Crit Care Med 2002 ; 165 : 800 – 804 . 11897647
8 Doran AK Ivy DD Barst RJ et al. Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension . Int J Clin Pract Suppl 2008 ; 160 : 5 – 9 .
9 Oudiz RJ Widlitz A Beckmann XJ et al. Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension . Chest 2004 ; 126 : 90 – 94 . 15249447
10 Ivy DD Claussen L Doran A Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil . Am J Cardiol 2007 ; 99 : 696 – 698 . 17317374
11 Rosenzweig EB Kerstein D Barst RJ Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects . Circulation 1999 ; 99 : 1858 – 1865 . 10199883
12 Bourge RC Waxman AB Gomberg-Maitland M et al. Treprostinil administered to treat pulmonary arterial hypertension using a fully implantable programmable intravascular delivery system: Results of the DelIVery for PAH Trial . Chest 2016 ; 150 : 27 – 34 . 27396777
13 Ewert R Halank M Bruch L et al. A case series of patients with severe pulmonary hypertension receiving an implantable pump for intravenous prostanoid therapy . Am J Respir Crit Care Med 2012 ; 186 : 1196 – 1198 . 23204382
14 Ewert R Richter MJ Steringer-Mascherbauer R et al. Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension . Clin Res Cardiol 2017 ; 106 : 776 – 783 . 28429083
15 Waxman AB McElderry HT Gomberg-Maitland M et al. Totally implantable IV treprostinil therapy in pulmonary hypertension assessment of the implantation procedure . Chest 2017 ; 152 : 1128 – 1134 . 28583617
16 Richter MJ Ewert R Warnke C et al. Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension . Clin Res Cardiol 2017 ; 106 : 174 – 182 . 27670656
17 Barst RJ Ivy DD Gaitan G et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension . Circulation 2012 ; 125 : 324 – 334 . 22128226
18 Burgess G Hoogkamer H Collings L et al. Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil . Eur J Clin Pharmacol 2008 ; 64 : 43 – 50 . 18040672
19 Grünig E Ohnesorge J Benjamin N et al. Plasma drug concentrations in patients with pulmonary arterial hypertension on combination treatment . Respiration 2017 ; 94 : 26 – 37 . 28494463
20 Tricumed Medizintechnik GmbH. Dringende Sicherheitsinformation: mögliche Mehrförderung bei der implantierbaren Infusionspumpe Lenus pro in Verbindung mit dem Medikament Remodulin bei mehrjähriger Anwendung, https://bfarm.johner-institut.de/Documents/7124-13_Kundeninfo_de.pdf (26 November 2013, accessed 10 May 2018) .
21 Marr CR McSweeney JE Mullen MP et al. Central venous line complications with chronic ambulatory infusion of prostacyclin analogues in pediatric patients with pulmonary arterial hypertension . Pulm Circ 2015 ; 5 : 322 – 326 . 26064457
22 Ivy DD Calderbank M Wagner BD et al. Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension . Infect Control Hosp Epidemiol 2009 ; 30 : 823 – 829 . 19637961
23 Malbezin S Gauss T Smith I et al. A review of 5434 percutaneous pediatric central venous catheters inserted by anesthesiologists . Paediatr Anaesth 2013 ; 23 : 974 – 979 . 23659462
24 Janik JE Conlon SJ Janik JS Percutaneous central access in patients younger than 5 years: Size does matter . J Pediatr Surg 2004 ; 39 : 1252 – 1256 . 15300539
※ AI-Helper는 부적절한 답변을 할 수 있습니다.